Benzodiazepines (Psy and mixed indications) updated on 02-10-2025

Ear, face and neck anomalies

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S15381
R63375
Noh - BZDs, 2022 Ear, face and neck malformations 1st trimester population based cohort retrospective unexposed, sick Adjustment: Yes BZD Coexposure: Not specified 1.04 [0.70;1.53] 27/40,846   1,835/3,053,381 1,862 40,846
ref
S15330
R63137
Ban - Diazepam (Other indications) (Controls unexposed, disease free), 2014 Ear, face and neck malformations 1st trimester retrospective cohort (claims database) unexposed, disease free excluded Adjustment: No BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) Indication BZD: Psychiatric diseases (depression, anxiety, ...) 1.64 [0.10;26.45] C
excluded (control group)
0/1,159   92/351,785 92 1,159
ref
S15327
R63107
Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014 Ear, face and neck malformations 1st trimester retrospective cohort (claims database) unexposed, sick Adjustment: No BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) Indication BZD: Psychiatric diseases (depression, anxiety, ...) 1.10 [0.06;19.34] C 0/1,159   7/19,193 7 1,159
ref
S17769
R75093
Robert - BZDs, 1994 Congenital anomalies of ear, face and neck 1st trimester case control unexposed (general population or NOS) Adjustment: No BZD Coexposure: Not specified 1.15 [0.38;2.76] 6/-   142/- 148 -
ref
Total 3 studies 1.05 [0.74;1.51] 2,017 42,005
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Noh - BZDs, 2022Noh - BZDs, 2022 1.04[0.70; 1.53]1,86240,84685%ROB confusion: moderateROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: low Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014Ban - Diazepam, 2014 1 1.10[0.06; 19.34]71,1592%ROB confusion: criticalROB selection: moderateROB classification: criticalROB missing: moderateROB mesure: unclearROB reporting: moderate Robert - BZDs, 1994Robert - BZDs, 1994 1.15[0.38; 2.76]148-13%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: unclearROB reporting: moderate Total (3 studies) I2 = 0% 1.05[0.74; 1.51]2,01742,0050.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Other indications) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.04[0.71; 1.53]1,86942,0050%NANoh - BZDs, 2022 Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014 2 case control studiescase control studies 1.15[0.43; 3.10]148- -NARobert - BZDs, 1994 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.15[0.43; 3.10]148- -NARobert - BZDs, 1994 1 unexposed, sickunexposed, sick 1.04[0.71; 1.53]1,86942,0050%NANoh - BZDs, 2022 Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014 2 Tags Adjustment   - No  - No 1.14[0.45; 2.92]1551,1590%NABan - Diazepam (Other indications) (Controls unexposed, sick), 2014 Robert - BZDs, 1994 2   - Yes  - Yes 1.04[0.70; 1.54]1,86240,846 -NANoh - BZDs, 2022 1 BZD Coexposure   - No (among psychiatric (ATD and/or p ...  - No (among psychiatric (ATD and/or psychotropics) medications) 1.10[0.06; 19.34]71,159 -NABan - Diazepam (Other indications) (Controls unexposed, sick), 2014 1   - Not specified  - Not specified 1.05[0.73; 1.52]2,01040,8460%NANoh - BZDs, 2022 Robert - BZDs, 1994 2 Indication BZD   - Psychiatric diseases (depression, a ...  - Psychiatric diseases (depression, anxiety, ...) 1.10[0.06; 19.34]71,159 -NABan - Diazepam (Other indications) (Controls unexposed, sick), 2014 1 All studiesAll studies 1.05[0.74; 1.51]2,01742,0050%NANoh - BZDs, 2022 Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014 Robert - BZDs, 1994 30.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 15330

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.20[0.47; 3.05]2401,1590%NABan - Diazepam (Other indications) (Controls unexposed, disease free), 2014 Robert - BZDs, 1994 2 unexposed, sick controlsunexposed, sick controls 1.04[0.71; 1.53]1,86942,0050%NANoh - BZDs, 2022 Ban - Diazepam (Other indications) (Controls unexposed, sick), 2014 20.510.01.0